Kevan E. Clemens
Plus aucun poste en cours
Profil
Kevan E.
Clemens formerly worked at Kosan Biosciences, Inc., as Director from 2005 to 2008, Ivory Capital Corp., as Director, Chelsea Therapeutics International Ltd., as Independent Director from 2012 to 2014, MEI Pharma, Inc., as Independent Non-Executive Director from 2014 to 2021, Hoffmann-La Roche, Inc., as Executive Vice President & Business Director, Specialty Care, Inc., as Vice President, and de Syntex & Roche SA de CV, as Head-Pharmacoeconomics & Pricing.
Dr. Clemens received his doctorate degree from University College London.
Anciens postes connus de Kevan E. Clemens
| Sociétés | Poste | Fin |
|---|---|---|
| MEI PHARMA, INC. | Directeur/Membre du Conseil | 22/11/2021 |
| CHELSEA THERAPEUTICS INTERNATIONAL LTD. | Président | 11/07/2012 |
Kosan Biosciences, Inc.
 Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Directeur/Membre du Conseil | 26/06/2008 |
| Ivory Capital Corp. | Directeur/Membre du Conseil | 02/08/2005 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | 01/01/2004 |
Formation de Kevan E. Clemens
| University College London | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MEI PHARMA, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
| Ivory Capital Corp. | Finance |
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Health Technology |
| de Syntex & Roche SA de CV | |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Chelsea Therapeutics International Ltd.
 Chelsea Therapeutics International Ltd. BiotechnologyHealth Technology Chelsea Therapeutics International Ltd. acquires, develops and commercializes innovative products for the treatment of a variety of human diseases. The company was founded by Simon C. Pedder on June 17, 2005 and is headquartered in Charlotte, NC. | Health Technology |
Specialty Care, Inc.
 Specialty Care, Inc. Hospital/Nursing ManagementHealth Services Specialty Care, Inc. provides retirement and nursing services. The private company is based in Vaughan, Canada. | Health Services |
